AI Product

Ibex Medical Analytics — Digital Pathology

Clinical-grade AI pathology platform for prostate, breast, lung, and gastric cancer detection, grading, and IHC biomarker quantification, with biopharma extensions…

Intelligence Summary

Product
  • Active
  • Verified public sources
  • Developer Ibex Medical Analytics
  • Category Digital Pathology
  • Status Active
  • Latest update 2016: Ibex founded; company materials describe leadership in AI-powered pathology since that year.
  • Documentation Official page
  • Last reviewed Jul 2026
6 Technologies

Official product page

Target customer

Pathology laboratories, health systems, diagnostic providers, and pharmaceutical sponsors requiring standardized AI-assisted tissue analysis.

Features & capabilities

Industries: AI in Healthcare; Digital Pathology

Related reports

Related insights

Overview

Clinical-grade AI pathology platform for prostate, breast, lung, and gastric cancer detection, grading, and IHC biomarker quantification, with biopharma extensions for trial pathology and companion diagnostic development.

Product and company

Ibex Medical Analytics — Digital Pathology is a verified product offering linked to the Brel Digital company profile for Ibex Medical Analytics.

Use cases

Clinical-grade AI pathology platform for prostate, breast, lung, and gastric cancer detection, grading, and IHC biomarker quantification, with biopharma extensions for trial pathology and companion diagnostic development.

Target customer

Pathology laboratories, health systems, diagnostic providers, and pharmaceutical sponsors requiring standardized AI-assisted tissue analysis.

Technologies

Primary technologies assigned from the linked company profile: Computer Vision, Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.

Sources and references

  • Official product / company source: https://ibex-ai.com/hnl-lab-medicine-partnership-press-release/
  • Supporting source: https://ibex-ai.com/about/

Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.

Last reviewed

This product profile was last reviewed on 2026-07-14.

Correction request

If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.

Features and capabilities

  • Clinical-grade AI pathology platform for prostate, breast, lung, and gastric cancer detection, grading, and IHC biomarker quantification, with biopharma extensions for trial pathology and companion diagnostic development.

Extracted from the linked company product description already verified on Brel. No capabilities were invented.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Enquire about this product profile

Messages are delivered to contact@breldigital.com.